· News · News Desk
A new study flagged by ABC News warns that GLP-1 weight loss drugs may be misused by patients with active or prior eating disorders. Screening gaps, prescriber blind spots, and what risk frameworks are starting to recommend.
This brief is part of the Novusyn Research news desk. We track peptide clinical readouts, regulatory actions, and pharma developments in neutral, evidence-led language for scientifically literate readers.
For related context, see the full news desk, clinical trials tracker, regulation tracker, compound directory, and guides library.